InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
80.57
(
-0.01%
)
Bitcoin
69,553.23
(
2.59%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120144
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ocyanblue post# 5618

Friday, 04/11/2008 11:43:46 AM

Friday, April 11, 2008 11:43:46 AM

Post# of 12660
Another lame attempt by you at diversion and obfuscation—this time with drivel about broken glass and such.

You cannot will away program-survival bias by labeling it as trivial. To the contrary, understanding program-survival bias is an absolutely critical element to biotech investing. If you don’t get it, you will be doomed to overestimating the chances of clinical success in pivotal trials over and over again.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up